Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
13
直前連結会計年度末の連結純資産比（取得価額・アドバイザリー費用等を含む取得金額合計、13％未満）Wording
Conditional
How definitive the wording is.This transaction
Acquisition of shares (making the company a subsidiary)Disclosing companyUbicom Holdings,Inc.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Proposal, implementation, maintenance and support of receipt computers, electronic medical records and peripheral equipment for clinics and small hospitals as a Japan Medical IT Support provider; medical information systems; development and sales of proprietary products; and consulting services
Location Kam isato Town, Kodama County, Saitama PrefectureShare capital ¥83.75 millionDate of incorporation January 2000
Net Sales884,209千円（2025年9月期）
Operating profit153,925千円（2025年9月期）
Net income for the current fiscal year101,966千円（2025年9月期）
Net assets421,935千円（2025年9月期）
Consideration and expenses
Acquisition price取得価額につきましては、相手先との守秘義務契約に基づき、公表を控えさせていただきます。
Type of ConsiderationCash (internal funds)
Funding arrangementsInternal funds
Impact on Business Performance
本件が当社グループの今期業績に与える影響は算定中でありますが、中長期的に当社の業績の向上に資するものと考えております。
Procedures and assumptions
Valuation methodology独立した第三者算定機関による対象会社の株式価値算定書
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares (making the company a subsidiary) |
| Name of the Subject Company | ラジエンスウエア株式会社 |
| Business Description of the Subject Company | Proposal, implementation, maintenance and support of receipt computers, electronic medical records and peripheral equipment for clinics and small hospitals as a Japan Medical IT Support provider; medical information systems; development and sales of proprietary products; and consulting services |
| Location of the Subject Company | Kam isato Town, Kodama County, Saitama Prefecture |
| Capital Stock of the Subject Company | ¥83.75 million |
| Date of Establishment of the Subject Company | January 2000 |
| Net Sales of the Subject Company | 884,209千円（2025年9月期） |
| Operating Profit of the Subject Company | 153,925千円（2025年9月期） |
| Net Income of the Subject Company | 101,966千円（2025年9月期） |
| Net Assets of the Subject Company | 421,935千円（2025年9月期） |
| Acquisition price | 取得価額につきましては、相手先との守秘義務契約に基づき、公表を控えさせていただきます。 |
| Type of Consideration | Cash (internal funds) |
| Number of shares acquired | 15,550株、議決権の数15,550個 |
| Voting rights ownership percentage | Before 0.0％ → after 100％ |
| Funding arrangements | Internal funds |
| Impact on Business Performance | 本件が当社グループの今期業績に与える影響は算定中でありますが、中長期的に当社の業績の向上に資するものと考えております。 |
| Date of board resolution | 19 March 2026 |
| Contract Date | 30 March 2026 (scheduled) |
| Execution Date / Effective Date | 1 April 2026 (scheduled) |
| Valuation methodology | 独立した第三者算定機関による対象会社の株式価値算定書 |
Items this document does not state (12)
Counterparty nameExpenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodGoodwill amountAmount of extraordinary income (loss)Independent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.メディカル事業で地域密着型販売代理店をグループ化し、間接販売からグループ直販モデルへ転換するためです。ラジエンスウエア社の顧客基盤・営業力と自社の医療ITソリューションを組み合わせ、販路拡大、顧客基盤の強化、クロスセル、収益性およびストック型収益の向上を目指すとしています。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.